We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Revolutionizing Hypertension Management: Machine Learning to Decode Multiorgan Damage and New Disease Phenotypes
Cardiologymachine learningHypertension

Revolutionizing Hypertension Management: Machine Learning to Decode Multiorgan Damage and New Disease Phenotypes

By MedXY|Aug 8, 2026

Highlight This unprecedented large-scale multinational study developed a semisupervised contrastive machine learning framework that generates a global

Decoding Registry-Based Randomised Controlled Trials: Advancing Clinical Evidence Through Standardisation and Taxonomy
CardiologytaxonomyRRCT

Decoding Registry-Based Randomised Controlled Trials: Advancing Clinical Evidence Through Standardisation and Taxonomy

By MedXY|Aug 7, 2026

Registry-based randomised controlled trials (RRCTs) offer promising efficiencies and external validity over traditional RCTs, yet lack consistent definitions and registration standards. A proposed taxonomy and adherence to CONSORT-ROUTINE a

Cardiac Resynchronization Therapy With or Without Defibrillator in Nonischemic Cardiomyopathy: Evidence Synthesis and Clinical Implications from DECIDE-CRT and Related Studies
Cardiologyheart failureimplantable cardioverter-defibrillator

Cardiac Resynchronization Therapy With or Without Defibrillator in Nonischemic Cardiomyopathy: Evidence Synthesis and Clinical Implications from DECIDE-CRT and Related Studies

By MedXY|Aug 7, 2026

This review synthesizes contemporary evidence on the survival impact of adding defibrillators to CRT in nonischemic cardiomyopathy, highlighting heterogeneous results including the DECIDE-CRT study and underscoring the need for personalized

Decoding the U-Shaped Relationship Between Left Ventricular Size and Mortality in Heart Failure Patients
Cardiologyechocardiographyheart failure

Decoding the U-Shaped Relationship Between Left Ventricular Size and Mortality in Heart Failure Patients

By MedXY|Aug 7, 2026

A large Chinese cohort study reveals a U-shaped association between left ventricular end-diastolic diameter and mortality in heart failure, highlighting both small and large ventricular sizes as independent risk factors.

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation
CardiologyMitral RegurgitationMultivalve Disease

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation

By MedXY|Sep 11, 2026

This propensity-matched study shows that in patients undergoing tricuspid TEER for severe TR, untreated moderate MR is linked to worse survival, while combined mitral and tricuspid TEER improves mortality and functional outcomes, highlighti

Seven-Year Health Outcomes After TAVR Versus SAVR in Low-Risk Aortic Stenosis Patients: Insights from the PARTNER 3 Trial
CardiologyTAVRlong-term outcomes

Seven-Year Health Outcomes After TAVR Versus SAVR in Low-Risk Aortic Stenosis Patients: Insights from the PARTNER 3 Trial

By MedXY|Aug 18, 2026

In low-risk severe aortic stenosis patients, both TAVR and SAVR provide sustained health status improvements over seven years, with TAVR offering faster early recovery but similar long-term health outcomes.

Left Ventricular Hypertrabeculation in Dilated Cardiomyopathy: Prognostic Insights and Clinical Implications
CardiologyCardiac prognosisDilated cardiomyopathy

Left Ventricular Hypertrabeculation in Dilated Cardiomyopathy: Prognostic Insights and Clinical Implications

By MedXY|Aug 7, 2026

This study reveals that left ventricular hypertrabeculation, common in dilated cardiomyopathy, does not increase embolic risk or adverse outcomes, challenging previous concerns and guiding clinical management.

Rethinking Race/Ethnicity in Cardiovascular Risk Assessment: The Race-Free MESA Risk Score
Cardiologycardiovascular riskMESA score

Rethinking Race/Ethnicity in Cardiovascular Risk Assessment: The Race-Free MESA Risk Score

By MedXY|Aug 7, 2026

A race-free adaptation of the MESA risk score estimates 10-year coronary heart disease risk with comparable accuracy to the original, challenging the necessity of including race/ethnicity in cardiovascular risk prediction.

Optimizing Donor Heart Preservation: Superior Outcomes with 10°C Versus 4-8°C in Adult Heart Transplantation
CardiologyHeart Transplantationgraft function

Optimizing Donor Heart Preservation: Superior Outcomes with 10°C Versus 4-8°C in Adult Heart Transplantation

By MedXY|Aug 5, 2026

A multicenter study reveals that preserving donor hearts at 10°C results in better early graft function and one-year survival than traditional 4-8°C storage, suggesting a new standard for heart transplant preservation.

Women’s Heart Centres: The ESC Consensus on Organized, Sex-Sensitive Cardiovascular Care
Cardiologycardiovascular diseaseCardio-Oncology

Women’s Heart Centres: The ESC Consensus on Organized, Sex-Sensitive Cardiovascular Care

By MedXY|Aug 5, 2026

The 2026 ESC clinical consensus outlines creation of multidisciplinary Women’s Heart Centres to close gaps in diagnosis, management, and research for women’s cardiovascular disease across the life course.

Evaluating Elective Left Ventricular Unloading in High-Risk PCI: Insights from the CHIP-BCIS3 Substudy
CardiologyhemodynamicsLeft ventricular unloading

Evaluating Elective Left Ventricular Unloading in High-Risk PCI: Insights from the CHIP-BCIS3 Substudy

By MedXY|Aug 5, 2026

This substudy of the CHIP-BCIS3 trial assessed the effects of elective left ventricular unloading via microaxial flow pump during complex PCI, finding reduced inotrope use but no significant hemodynamic or myocardial stunning benefits.

Extracranial Bleeding Risk on Oral Anticoagulants in Atrial Fibrillation: Insights from COMBINE-AF Analysis
Cardiologyoral anticoagulantsextracranial bleeding

Extracranial Bleeding Risk on Oral Anticoagulants in Atrial Fibrillation: Insights from COMBINE-AF Analysis

By MedXY|Aug 5, 2026

This study evaluates the incidence, severity, and predictors of extracranial bleeding in atrial fibrillation patients on oral anticoagulants, highlighting its substantial burden beyond major bleeds and informing bleeding risk management.

Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea Patients
CardiologyInsomniaCPAP Therapy

Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea Patients

By MedXY|Aug 4, 2026

In patients with OSA and elevated blood pressure, comorbid insomnia is linked to a significantly greater blood pressure reduction following short-term CPAP therapy, highlighting the clinical importance of addressing both sleep disorders.

Exploring the Impact of Multiple Pregnancies on Subclinical Left Ventricular Function in Healthy Women
CardiologyPregnancyLeft Ventricular Dysfunction

Exploring the Impact of Multiple Pregnancies on Subclinical Left Ventricular Function in Healthy Women

By MedXY|Aug 18, 2026

This study reveals that higher parity is associated with subtle reductions in myocardial strain during pregnancy, suggesting cumulative cardiovascular effects despite normal ejection fraction.

Validating VasCog-2-WSO Criteria: Early MRI Detection of Vascular Cognitive Impairment and Mortality Risk in Stroke- and Dementia-Free Adults
Cardiologycardiovascular riskvascular cognitive impairment

Validating VasCog-2-WSO Criteria: Early MRI Detection of Vascular Cognitive Impairment and Mortality Risk in Stroke- and Dementia-Free Adults

By MedXY|Aug 4, 2026

The VasCog-2-WSO criteria effectively detect MRI-defined vascular cognitive impairment in asymptomatic adults, correlating with increased cardiovascular risk and mortality, highlighting their utility for early diagnosis and community risk s

Long-Term Survival Outcomes in Asymptomatic Patients with Degenerative Mitral Regurgitation: Insights from a 25-Year Prospective Cohort Study
CardiologyMitral Regurgitationeffective regurgitant orifice

Long-Term Survival Outcomes in Asymptomatic Patients with Degenerative Mitral Regurgitation: Insights from a 25-Year Prospective Cohort Study

By MedXY|Aug 4, 2026

This 25-year prospective study evaluates the prognostic value of quantified mitral regurgitation (MR) severity and shows that early surgical intervention in upper-moderate MR improves long-term survival in asymptomatic patients.

Electrophysiology-Guided Surgical Ablation During Pulmonary Valve Replacement: A Paradigm Shift in Managing Arrhythmia Risk in Adults with Repaired Tetralogy of Fallot
Cardiology心室頻脈Tetralogy of Fallot

Electrophysiology-Guided Surgical Ablation During Pulmonary Valve Replacement: A Paradigm Shift in Managing Arrhythmia Risk in Adults with Repaired Tetralogy of Fallot

By MedXY|Aug 4, 2026

In adults with repaired Tetralogy of Fallot undergoing pulmonary valve replacement, an electrophysiology-guided ablation strategy significantly reduces ventricular tachycardia inducibility and long-term arrhythmic risk compared to empiric a

Equivalence of Nongated and Gated Coronary Artery Calcium Scoring in Predicting Cardiovascular Events: Insights from MESA Exam 5
CardiologyCACcardiovascular risk prediction

Equivalence of Nongated and Gated Coronary Artery Calcium Scoring in Predicting Cardiovascular Events: Insights from MESA Exam 5

By MedXY|Aug 4, 2026

Nongated coronary artery calcium (CAC) scoring from routine chest CT scans can predict cardiovascular events as reliably as standard gated CAC scans, offering widespread opportunities for risk stratification and preventive care.

Dapagliflozin and Lipoprotein Metabolism in Type 2 Diabetes: Preserving LDL Catabolism and Normalizing VLDL Processing
CardiologyDapagliflozinLDL catabolism

Dapagliflozin and Lipoprotein Metabolism in Type 2 Diabetes: Preserving LDL Catabolism and Normalizing VLDL Processing

By MedXY|Jul 31, 2026

This study demonstrates that dapagliflozin does not impair LDL catabolism but favorably shifts VLDL1 and VLDL2 catabolism toward normal physiology in type 2 diabetes, potentially contributing to reduced atherosclerosis risk.

Reassessing Diagnostic Tools for Peripheral Arterial Disease in Diabetes: Insights from the DMPAD Study
CardiologydiabetesDiagnostic accuracy

Reassessing Diagnostic Tools for Peripheral Arterial Disease in Diabetes: Insights from the DMPAD Study

By MedXY|Aug 4, 2026

Common bedside tests for peripheral arterial disease in diabetic patients show poor sensitivity, challenging their clinical reliability compared to advanced imaging modalities.

Prev
12 / 25
1…1011121314…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles